9,782,454 covering the company's Hybridtide® platform technology — a revolutionary peptide technology originally developed in the academic ...
9,782,454 covering the company's Hybridtide® platform technology — a revolutionary peptide technology originally developed in the academic ...
... Sweden--(Business Wire)--Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide ...
... fully human antibodies that bind major histocompatibility complex (MHC)/peptide complexes displaying fragments of intracellular proteins of interest.
“APL-2 is a synthetic cyclic peptide conjugated to a polyethylene glycol polymer that binds specifically to C3 and C3b, effectively blocking all three ...
SHANGHAI, China I October 10, 2017 I Generon Corporation, an innovative biopharmaceutical company in China developing novel biological ...
TORONTO, Canada and HOUSTON, TX, USA I October 10, 2017 I Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX "MDNA"), ...
Arecor says its protein and peptide formulation technology can provide a competitive advantage for biosimilar developers as it announces its first ...
Boston Biomedical Announces Orphan Drug Designation by FDA for Investigational WT1 Cancer Peptide Vaccine DSP-7888 in Brain Cancer.
Our Intravail® drug delivery technology enables the non-invasive systemic delivery of a broad range of protein, peptide and non-peptide drugs that ...
Metablok is a novel peptide drug candidate in the Arch development pipeline and a potential treatment for inflammation, sepsis and cancer metastasis.